Export financials
The Sherwin-Williams Company (SHW)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

The Sherwin-Williams Company Balance Sheet 2025-2006 | SHW
Brief overview of The Sherwin-Williams Company's financial position
This overview follows the five latest available annual observations between 2015 and 2019.
Total assets increased by +253.9%, from $5.8 billion to $20.5 billion. A CAGR near 37.2% points to substantial expansion.
Assets outpaced liabilities, +253.9% versus +232.5%. Dependence on external funding declined.
Internal capital represents 20.1% of the balance sheet versus 15% five periods ago. The cushion is thin.
Net debt stands at $8.5 billion, or 2.07x of equity. The debt cushion is limited.
The cash share moved from 3.6% to 0.8%. A higher figure generally provides more room in an adverse scenario.
Accumulated earnings ended at $7.4 billion, a change of +128.2%. They remain an important part of the capital base.
Balance sheet takeaway
The Sherwin-Williams Company has a workable but not unconditionally strong balance sheet. Resilience depends on sustained earnings and liability control.
Annual Balance Sheet The Sherwin-Williams Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
9.59 B | 8.43 B | 8.55 B | 9.82 B | 8.83 B | 8.43 B | 8.52 B | 9.19 B | 10.3 B | 1.06 B | 1.76 B | 1.76 B | 977 M | 842 M | 961 M | 598 M | 726 M | 291 M | 281 M | - |
Long Term Debt |
9.32 B | 8.18 B | 8.38 B | 9.59 B | 8.59 B | 8.27 B | 8.05 B | 8.71 B | 9.89 B | 1.21 B | 1.92 B | 1.12 B | 1.12 B | 1.63 B | 639 M | 648 M | 783 M | 304 M | 293 M | - |
Long Term Debt Current |
480 M | 467 M | 449 M | 425 M | 410 M | 387 M | 372 M | 307 M | 1.18 M | 700 M | 3.15 M | 3.26 M | 503 M | 3.69 M | 7.82 M | 7.88 M | 12.3 M | 13.6 M | 14.9 M | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 11.9 B | 11.1 B | 12.3 B | 2.04 B | 2.78 B | 2.03 B | 2.08 B | 2.57 B | 1.55 B | - | - | - | - | - |
Total Current Liabilities |
6.92 B | 6.81 B | 6.63 B | 5.96 B | 5.72 B | 4.59 B | 4.52 B | 4.3 B | 3.99 B | 2.83 B | 2.14 B | 2.68 B | 2.53 B | 1.88 B | 2.16 B | 2.06 B | 1.39 B | 1.94 B | 2.14 B | - |
Total Liabilities |
- | - | - | - | - | - | 16.4 B | 15.4 B | 16.3 B | 4.87 B | 4.92 B | 4.71 B | 4.61 B | 4.44 B | 3.71 B | - | - | - | - | - |
Deferred Revenue |
427 M | 386 M | 366 M | 293 M | 260 M | 266 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.03 B | 7.25 B | 5.29 B | 3.52 B | 2.12 B | 844 M | 7.37 B | 6.25 B | 5.5 B | 4.05 B | 3.23 B | 2.42 B | 1.77 B | 1.23 B | 756 M | 4.82 B | 4.52 B | 4.25 B | 3.94 B | - |
Total Assets |
25.9 B | 23.6 B | 23 B | 22.6 B | 20.7 B | 20.4 B | 20.5 B | 19.1 B | 20 B | 6.75 B | 5.79 B | 5.71 B | 6.38 B | 6.23 B | 5.23 B | 5.17 B | 4.32 B | 4.42 B | 4.86 B | - |
Cash and Cash Equivalents |
207 M | 210 M | 277 M | 199 M | 166 M | 227 M | 162 M | 156 M | 204 M | 890 M | 206 M | 40.7 M | 745 M | 863 M | 32.7 M | 58.6 M | 69.3 M | 26.2 M | 27.3 M | 469 M |
Book Value |
25.9 B | 23.6 B | 23 B | 22.6 B | 20.7 B | 20.4 B | 4.12 B | 3.73 B | 3.69 B | 1.88 B | 868 M | 996 M | 1.77 B | 1.79 B | 1.52 B | 5.17 B | 4.32 B | 4.42 B | 4.86 B | - |
Total Shareholders Equity |
4.6 B | 4.05 B | 3.72 B | 3.1 B | 2.44 B | 3.61 B | 4.12 B | 3.73 B | 3.65 B | 1.88 B | 868 M | 996 M | 1.77 B | 1.79 B | 1.52 B | 1.61 B | 1.49 B | 1.61 B | 1.79 B | 1.99 B |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet The Sherwin-Williams Company
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q4 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.7 B | 1.66 B | 9.32 B | 1.59 B | 1.58 B | 7.83 B | 7.83 B | 1.56 B | 1.5 B | 1.5 B | 1.5 B | 1.51 B | 1.5 B | 1.5 B | 1.49 B | 1.51 B | 1.49 B | 1.48 B | 1.48 B | 1.47 B | 1.43 B | 1.43 B | 1.4 B | 1.43 B | 1.42 B | 1.39 B | 1.37 B | 1.37 B | 1.35 B | 1.36 B | 1.37 B | 9.02 B | 8.71 B | 9.72 B | 9.89 B | 9.89 B | 10.1 B | 10.8 B | 1.21 B | 1.21 B | 1.91 B | 1.91 B | 1.91 B | 1.91 B | 1.91 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 1.63 B | 1.63 B | 1.63 B | 1.63 B | 635 M | 636 M | 638 M | 639 M | 641 M | 644 M | 651 M | 648 M | 705 M | 700 M | 783 M | 783 M | 289 M | 291 M |
Deferred Revenue |
443 M | 368 M | 294 M | 427 M | 362 M | 304 M | 246 M | 386 M | 363 M | 306 M | 254 M | 366 M | 325 M | 267 M | 229 M | 293 M | 301 M | 253 M | 211 M | 260 M | 269 M | 228 M | 183 M | 266 M | 244 M | 201 M | 176 M | 243 M | 225 M | 237 M | 204 M | 277 M | 246 M | 180 M | 153 M | 209 M | 209 M | 209 M | 209 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
2.64 B | 2.01 B | 1.37 B | 1.03 B | 8.74 B | 8.11 B | 7.55 B | 7.25 B | 6.95 B | 6.32 B | 5.61 B | 5.29 B | 5.09 B | 4.48 B | 3.84 B | 3.52 B | 3.29 B | 2.76 B | 2.34 B | 2.12 B | 1.96 B | 1.6 B | 1.1 B | 844 M | 8.62 B | 8.04 B | 7.56 B | 7.37 B | 7.22 B | 6.75 B | 6.39 B | 6.25 B | 6.23 B | 5.95 B | 5.63 B | 5.46 B | 4.69 B | 4.45 B | 4.21 B | 4.05 B | 3.92 B | 3.62 B | 3.32 B | 3.23 B | 3.09 B | 2.78 B | 2.49 B | 2.42 B | 2.35 B | 2.07 B | 1.83 B | 1.77 B | 1.71 B | 1.5 B | 1.29 B | 1.23 B | 1.2 B | 1 B | 816 M | 756 M | 780 M | 637 M | 497 M | 4.82 B | 4.79 B | 4.65 B | 4.51 B | 4.52 B | 4.49 B | 4.36 B |
Total Assets |
27 B | 27 B | 26.4 B | 25.9 B | 26.2 B | 25.4 B | 24.6 B | 23.6 B | 24 B | 23.7 B | 23.4 B | 23 B | 23 B | 23.2 B | 23.1 B | 22.6 B | 22.2 B | 22.1 B | 21.7 B | 20.7 B | 20.7 B | 20.5 B | 20.4 B | 20.4 B | 20.8 B | 20.5 B | 20.6 B | 20.5 B | 20.9 B | 21.2 B | 21 B | 19.1 B | 19.9 B | 20.1 B | 20.3 B | 19.9 B | 20.8 B | 20.7 B | 6.99 B | 6.75 B | 6.92 B | 6.67 B | 6.04 B | 5.78 B | 6.09 B | 6.13 B | 5.85 B | 5.7 B | 6.32 B | 6.34 B | 6.19 B | 6.38 B | 6.92 B | 6.41 B | 6.17 B | 6.23 B | 5.63 B | 5.63 B | 5.46 B | 5.23 B | 5.49 B | 5.63 B | 5.44 B | 5.17 B | 5.18 B | 4.74 B | 4.51 B | 4.32 B | 4.45 B | 4.5 B |
Cash and Cash Equivalents |
264 M | 294 M | 217 M | 207 M | 242 M | 270 M | 200 M | 210 M | 238 M | 200 M | 180 M | 277 M | 503 M | 209 M | 151 M | 199 M | 130 M | 313 M | 401 M | 166 M | 313 M | 220 M | 315 M | 227 M | 620 M | 188 M | 238 M | 162 M | 190 M | 146 M | 94.4 M | 156 M | 182 M | 155 M | 159 M | 204 M | 208 M | 210 M | 1.02 B | 890 M | 703 M | 403 M | 70.5 M | 206 M | 91 M | 75.1 M | 64 M | 40.7 M | 261 M | 267 M | 366 M | 745 M | 1.04 B | 741 M | 614 M | 863 M | 55.2 M | 46.6 M | 25.5 M | 32.7 M | 46 M | 71.6 M | 53.9 M | 58.6 M | 64.9 M | 48.4 M | 91.2 M | 69.3 M | 32.8 M | 49.3 M |
Book Value |
27 B | 27 B | 26.4 B | 25.9 B | 26.2 B | 25.4 B | 24.6 B | 23.6 B | 24 B | 23.7 B | 23.4 B | 23 B | 23 B | 23.2 B | 23.1 B | 22.6 B | 22.2 B | 22.1 B | 21.7 B | 20.7 B | 20.7 B | 20.5 B | 20.4 B | 20.4 B | 20.8 B | 20.5 B | 20.6 B | 20.5 B | 20.9 B | 21.2 B | 21 B | 19.1 B | 19.9 B | 20.1 B | 20.3 B | 19.9 B | 20.8 B | 20.7 B | 6.99 B | 6.75 B | 6.92 B | 6.67 B | 6.04 B | 5.78 B | 6.09 B | 6.13 B | 5.85 B | 5.7 B | 6.32 B | 6.34 B | 6.19 B | 6.38 B | 6.92 B | 6.41 B | 6.17 B | 6.23 B | 5.63 B | 5.63 B | 5.46 B | 5.23 B | 5.49 B | 5.63 B | 5.44 B | 5.17 B | 5.18 B | 4.74 B | 4.51 B | 4.32 B | 4.45 B | 4.5 B |
Total Shareholders Equity |
3.98 B | 3.85 B | 4.43 B | 4.6 B | 4.43 B | 4.4 B | 4.13 B | 4.05 B | 4.16 B | 3.75 B | 3.5 B | 3.72 B | 3.78 B | 3.63 B | 3.17 B | 3.1 B | 2.6 B | 2.22 B | 2.23 B | 2.44 B | 2.69 B | 2.84 B | 3.08 B | 3.61 B | 4.21 B | 3.87 B | 3.29 B | 4.12 B | 4.02 B | 3.75 B | 3.46 B | 3.73 B | 3.97 B | 3.7 B | 3.65 B | 3.65 B | 2.74 B | 2.39 B | 2.07 B | 1.88 B | 1.6 B | 1.25 B | 1 B | 868 M | 976 M | 757 M | 469 M | 996 M | 1.35 B | 1.52 B | 1.65 B | 1.77 B | 1.87 B | 1.87 B | 1.81 B | 1.79 B | 1.78 B | 1.54 B | 1.51 B | 1.52 B | 1.65 B | 1.75 B | 1.61 B | 1.61 B | 1.64 B | 1.53 B | 1.5 B | 1.49 B | 1.7 B | 1.73 B |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of The Sherwin-Williams Company, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Specialty chemicals
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Gulf Resources
GURE
|
- | -2.8 % | $ 44.6 M | ||
|
Ecolab
ECL
|
$ 306.07 | -0.22 % | $ 86.7 B | ||
|
Quaker Chemical Corporation
KWR
|
$ 154.38 | -2.15 % | $ 2.7 B | ||
|
Linde PLC
LIN
|
$ 521.78 | 0.28 % | $ 245 B | ||
|
LyondellBasell Industries N.V.
LYB
|
$ 60.39 | 1.5 % | $ 19.5 B | ||
|
Ingevity Corporation
NGVT
|
$ 60.85 | -2.48 % | $ 2.2 B | ||
|
Northern Technologies International Corporation
NTIC
|
$ 7.46 | 0.13 % | $ 70.7 M | ||
|
PPG Industries
PPG
|
$ 124.42 | -0.12 % | $ 28.2 B | ||
|
Element Solutions Inc
ESI
|
$ 32.76 | -0.61 % | $ 7.93 B | ||
|
Stepan Company
SCL
|
$ 67.23 | -1.26 % | $ 1.54 B | ||
|
SenesTech
SNES
|
$ 1.05 | -7.91 % | $ 3.44 M | ||
|
Gevo
GEVO
|
$ 1.42 | -3.74 % | $ 332 M | ||
|
Crown ElectroKinetics Corp.
CRKN
|
- | -16.67 % | $ 15.5 M | ||
|
WD-40 Company
WDFC
|
$ 224.11 | 0.25 % | $ 3.02 B | ||
|
Westlake Chemical Corporation
WLK
|
$ 63.28 | -1.33 % | $ 8.12 B | ||
|
International Flavors & Fragrances
IFF
|
$ 83.22 | -1.43 % | $ 21.3 B | ||
|
Albemarle Corporation
ALB
|
$ 94.95 | -4.21 % | $ 11.2 B | ||
|
Venator Materials PLC
VNTR
|
- | - | $ 5.4 M | ||
|
Chase Corporation
CCF
|
- | -0.01 % | $ 1.2 B | ||
|
Oil-Dri Corporation of America
ODC
|
$ 72.83 | -1.25 % | $ 1.05 B | ||
|
GCP Applied Technologies
GCP
|
- | - | $ 2.37 B | ||
|
Amyris
AMRS
|
- | -21.88 % | $ 16 M | ||
|
Sensient Technologies Corporation
SXT
|
$ 120.95 | -0.6 % | $ 5.11 B | ||
|
Trecora Resources
TREC
|
- | 0.41 % | $ 231 M | ||
|
Livent Corporation
LTHM
|
- | - | $ 2.84 B | ||
|
Cabot Corporation
CBT
|
$ 72.19 | 0.47 % | $ 3.88 B | ||
|
Avantor
AVTR
|
$ 15.58 | -2.11 % | $ 10.6 B | ||
|
Balchem Corporation
BCPC
|
$ 173.64 | -1.34 % | $ 5.6 B | ||
|
Axalta Coating Systems Ltd.
AXTA
|
$ 37.38 | -0.41 % | $ 8.07 B | ||
|
The Chemours Company
CC
|
$ 13.5 | 1.66 % | $ 2.03 B | ||
|
Avient Corporation
AVNT
|
$ 45.73 | -1.35 % | $ 4.18 B | ||
|
Green Plains
GPRE
|
$ 13.72 | -1.83 % | $ 926 M | ||
|
Core Molding Technologies
CMT
|
$ 22.57 | 0.85 % | $ 193 M | ||
|
Hawkins
HWKN
|
$ 153.36 | -0.78 % | $ 3.18 B | ||
|
Innospec
IOSP
|
$ 77.62 | -3.23 % | $ 1.93 B | ||
|
H.B. Fuller Company
FUL
|
$ 50.77 | -1.11 % | $ 2.77 B | ||
|
Hudson Technologies
HDSN
|
$ 4.44 | 1.14 % | $ 194 M | ||
|
PQ Group Holdings Inc.
PQG
|
- | 0.58 % | $ 2.14 B | ||
|
Koppers Holdings
KOP
|
$ 29.65 | 1.09 % | $ 589 M | ||
|
Orion Engineered Carbons S.A.
OEC
|
$ 4.18 | 3.09 % | $ 235 M | ||
|
NewMarket Corporation
NEU
|
$ 695.43 | 0.48 % | $ 6.53 B | ||
|
Loop Industries
LOOP
|
$ 0.26 | 3.02 % | $ 12.5 M | ||
|
Olin Corporation
OLN
|
$ 17.49 | -0.43 % | $ 2 B | ||
|
Kronos Worldwide
KRO
|
$ 8.21 | 1.48 % | $ 944 M | ||
|
RPM International
RPM
|
$ 106.36 | -0.02 % | $ 13.5 B | ||
|
Tredegar Corporation
TG
|
$ 5.79 | -1.86 % | $ 201 M | ||
|
Ferro Corporation
FOE
|
- | 0.27 % | $ 1.84 B | ||
|
W. R. Grace & Co.
GRA
|
- | 0.03 % | $ 4.64 B | ||
|
IKONICS Corporation
IKNX
|
- | -5.44 % | $ 57.2 M |